Merck (MRK) Accounts Payables (2009 - 2026)

Merck has disclosed Accounts Payables across 18 years of filings, most recently posting $3.9 billion for Q1 2026.

• In Q1 2026, Accounts Payables rose 2.09% year-over-year to $3.9 billion; the TTM figure through Mar 2026 stood at $3.9 billion (up 2.09% YoY), while the FY2025 annual figure was $4.4 billion, up 7.97% from the prior year.
• Accounts Payables declined to $3.9 billion in Q1 2026, from $4.4 billion in the prior quarter.
• Over the last five years, Accounts Payables for MRK reached as high as $4.4 billion in Q4 2025 and fell as low as $3.4 billion in Q3 2022.
• The 5-year median for Accounts Payables is $3.7 billion (2022), against an average of $3.8 billion.
• Annual changes were most pronounced in 2022 — Accounts Payables slipped 10.65% — and 2025, when it climbed 15.64%.
• A 5-year view of Accounts Payables shows it stood at $4.3 billion in 2022, then declined by 8.02% to $3.9 billion in 2023, then gained by 4.0% to $4.1 billion in 2024, then climbed by 7.97% to $4.4 billion in 2025, then fell by 12.28% to $3.9 billion in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.9 billion, $4.4 billion, and $4.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.